<?xml version="1.0" encoding="UTF-8"?>
<STUDY_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <STUDY center_name="BioProject" alias="PRJNA770908" accession="SRP341169">
    <IDENTIFIERS>
      <PRIMARY_ID>SRP341169</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioProject" label="primary">PRJNA770908</EXTERNAL_ID>
    </IDENTIFIERS>
    <DESCRIPTOR>
      <STUDY_TITLE>Monitoring the seesaw effect in S. aureus grown in a bioreactor</STUDY_TITLE>
      <STUDY_TYPE existing_study_type="Other"/>
      <STUDY_ABSTRACT>Over the past decade, daptomycin treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections has led to the emergence of daptomycin non-susceptible (DAP-NS) MRSA strains and a subsequent interest in combinatorial antibiotic therapies. The seesaw effect describes the correlation between daptomycin resistance and increased beta-lactam susceptibility in DAP-NS MRSA. In this study, we successfully produced the seesaw effect in MRSA strain N315 by exposure to incremental dosages of daptomycin followed by oxacillin in a bioreactor. WGS was employed to monitor the genomic changes that occurred following antibiotic treatment.</STUDY_ABSTRACT>
    </DESCRIPTOR>
  </STUDY>
</STUDY_SET>
